IMR Press / FBL / Volume 11 / Issue 3 / DOI: 10.2741/2013

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
The role of tumor metastasis suppressors in cancers of breast and prostate
Show Less
1 Department of Medical Microbiology and Immunology, Southern Illinois University School of Medicine, 801 N Rutledge St, Springfield, IL 62702, USA
Academic Editor:Kounosuke Watabe
Front. Biosci. (Landmark Ed) 2006, 11(3), 2845–2860; https://doi.org/10.2741/2013
Published: 1 September 2006
(This article belongs to the Special Issue Pathogenesis of tumor progression in breast and prostate cancer)
Abstract

Despite significant improvement in surgical techniques and chemotherapies, none of the current medical technologies "cure" metastatic disease, and the patients who have acquired metastatic cancer inevitably die from disseminated disease. Thus, there is a need for developing novel therapeutic approaches which can directly target metastatic tumor cells. However, advances in understanding the molecular mechanism of tumor metastases have lagged behind other developments in the cancer field. Tumor metastasis involves complex array of steps with each step requiring a coordination of the actions of many positive and negative factors. A number of tumor metastasis suppressors have been identified which suppress the formation of tumor metastasis without affecting the growth rate of the primary tumor. Such discoveries offer new approaches for curtailing tumor metastasis. This review summarizes our current understanding on these genes and their potential role in the progression of tumor metastases.

Keywords
Metastasis
Suppressor
Prostate
Breast
Tumorigenesis
Tumor
Cancer
Review
Share
Back to top